ALBANY, New York, August 11, 2016 /PRNewswire/ --

MRRSE has released a new market report titled "Mice Model Market (by Model Type, by Specialty, by Services, and by Geography): Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023". According to a market research report available on Market Research Reports Search Engine (MRRSE), the global mice model market stood at US$1 bn in 2014 and is expected to reach US$1.7 bn by 2023 at a 6.40% CAGR. There has been a rapid growth in the use of mice models to study human diseases in the recent past. Mice models have become indispensable for researchers experimenting with different treatment strategies. Growth in the number of applications of mice models is expected to propel the global mice model market till 2023.

The use of mice models in the discovery of new medicines has been seen since many decades. Mice models are popularly used for studying and evaluating various treatments, such as cancer, neurological disorders, metabolic anomalies, and cardiovascular diseases. Some of the more common drug discovery mice model applications are the development of therapeutic strategies for treating human diseases, drug screening, and screening of toxicity and safety of use of drugs and target identification, and validation. Factors such as rising worries about animal cruelty, animal safety ethics, and stringent regulatory framework are expected to negatively impact the growth of the global mice model market during the forecast period.

Read Complete Report @ http://www.mrrse.com/global-mice-model-market

Mice models have long been the backbone of fundamental and applied research in life sciences and continues to grow at a rapid rate. The mice model market has transformed since 2001, the year rodent genome was mapped. Mice models have a wide array of applications such as basic research, developing new therapeutic strategies for the treatment of human diseases, drug discovery and development research (such as target characterization, drug screening, and toxicity and safety evaluation), and preclinical studies of drug efficacy. Hundreds of mice models have been developed to study diseases such as cancer, Huntington's, Parkinson's, Duchenne and Becker muscular dystrophy, and amyotrophic lateral sclerosis (ALS). In the last 25 years, around 80% of discoveries in the biomedical research has been linked to research on mice.

Major factor boosting the growth of the market is the growing application of mice models not only in the field of basic research, but also in applied field of drug development and discovery. Development of mice models of human diseases has progressed rapidly in the past few years.

Read Full Table of Content @ http://www.mrrse.com/mice-model-market/toc

This report studies the global mice model market from five perspectives: by type of model, application, services, and geography. Based on type of model, the market has been segmented into hybrid/congenic, transplantation mouse, transgenic, knockout, carcinogen-induced and spontaneous mouse, outbred, inbred, and conditioned/surgically modified. Based on application, the market has been segmented into immunology, central nervous system, oncology, cardiovascular, diabetes, and metabolism & regulation. Some of the prominent services offered to end-users include breeding and rederivation, cryopreservation and cryorecovery, quarantine services, genetic testing, model in-licensing, in vivo and in vitro pharmacology services, genetically engineered model services and other services such as surgical and line rescue. Geographically, the market has been studied and estimated for six regions: North America, Europe, Asia Pacific, Latin America, Middle East & North Africa, and Rest of the World.

Inquiry on this report @ http://www.mrrse.com/enquiry/353

Based on geography, the mice model market has been segmented into North America, Europe, Asia Pacific, Latin America, MENA, and Rest of the World (RoW). North America was the largest market for mice model in 2014. Ongoing robust research activities for the development of drugs and biologics and presence of major pharmaceutical and biotechnology companies in the region are some of the factors responsible for the dominance of the region. Europe held the second largest share of the global mice model market in terms of revenue in 2014.

Market share analysis is also provided in the market overview section of the report for 2014 in terms of value (%). The report also provides important recommendations for market players and new entrants. These recommendations would enable existing market players to expand their market share and help new companies establish their presence in the mice model market across the globe. The report concludes with the company profiles section, which includes key information about major players in the market such as financial overview, business strategies, and recent developments. Key players mentioned in the report include Charles River Laboratories, Crescendo Biologics Limited, Deltagen, Inc., GenOway S.A., Harlan Laboratories, Inc., ImmunoGenes AG, Taconic Biosciences, Inc., Lexicon Pharmaceuticals, SAGE Labs, The Jackson Laboratory, Taconic Biosciences, Inc., and TransGenic, Inc.  

Get a Free Sample Copy of the Report @ http://www.mrrse.com/sample/353

About MRRSE 

A part of Research Moz Global, MRRSE stands for Market Research Reports Search Engine, the largest online catalog of latest market research reports based on industries, companies, and countries. MRRSE sources thousands of industry reports, market statistics, and company profiles from trusted entities and makes them available at a click. Besides well-known private publishers, the reports featured on MRRSE typically come from national statistics agencies, investment agencies, leading media houses, trade unions, governments, and embassies.

Contact
MRRSE
Corporate Office
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-730-0559
Email: sales@mrrse.com

SOURCE Research Moz Global